Tag: Cpvi-19

  • Chr. Hansen reports 5% organic growth and significant strategic progress in 2019/20

    Chr. Hansen reports 5% organic growth and significant strategic progress in 2019/20

    Delivers on guidance, launched new strategy and carried through three acquisitions in spite of COVID-19 CEO Mauricio Graber says: “2019/20 was a defining and extremely eventful year for Chr. Hansen. We launched our new 2025 Strategy to become a focused bioscience company and to grow a better world, naturally. We made three acquisitions over a short period of time –…

    Ler mais